Hamid Alinejad-Rokny

Years Active: 2022-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Peter Truong, Sylvie Shen, Swapna Joshi, Md Imtiazul Islam, Ling Zhong, Mark J Raftery, Ali Afrasiabi, Hamid Alinejad-Rokny, Mary Nguyen, Xiaoheng Zou, Golam Sarower Bhuyan, Chowdhury H Sarowar, Elaheh S Ghodousi, Olivia Stonehouse, Sara Mohamed, Cara E Toscan, Patrick Connerty, Purvi M Kakadia, Stefan K Bohlander, Katharine A Michie, Jonas Larsson, Richard B Lock, Carl R Walkley, Julie A I Thoms, Christopher J Jolly, John E Pimanda
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells. Nature communications 15 (1) (2024)
Peter Truong, Sylvie Shen, Swapna Joshi, Md Imtiazul Islam, Ling Zhong, Mark J Raftery, Ali Afrasiabi, Hamid Alinejad-Rokny, Mary Nguyen, Xiaoheng Zou, Golam Sarower Bhuyan, Chowdhury H Sarowar, Elaheh S Ghodousi, Olivia Stonehouse, Sara Mohamed, Cara E Toscan, Patrick Connerty, Purvi M Kakadia, Stefan K Bohlander, Katharine A Michie, Jonas Larsson, Richard B Lock, Carl R Walkley, Julie A I Thoms, Christopher J Jolly, John E Pimanda
TOPORS E3 ligase mediates resistance to hypomethylating agent cytotoxicity in acute myeloid leukemia cells. Nature communications 15 (1) (2024)
Narges Rezaie, Masroor Bayati, Mehrab Hamidi, Maedeh Sadat Tahaei, Sadegh Khorasani, Nigel H Lovell, James Breen, Hamid R Rabiee, Hamid Alinejad-Rokny
Somatic point mutations are enriched in non-coding RNAs with possible regulatory function in breast cancer. Communications biology 5 (1) (2022)

Hamid Alinejad-Rokny.css-eqlu8i{font-size:small;padding-left:4px;}